Maven Income and Growth VCT 3 (MIG3) Competitors GBX 47.40 +1.00 (+2.16%) As of 07/10/2025 03:08 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock MIG3 vs. CCPG, FAIR, IIT, JMI, SCF, FJV, PEMB, BIOG, KIT, and IBTShould you be buying Maven Income and Growth VCT 3 stock or one of its competitors? The main competitors of Maven Income and Growth VCT 3 include CVC Credit Partners European Opportunities (CCPG), Fair Oaks Income 2021 (FAIR), The Independent Investment Trust (IIT), JPMorgan UK Smaller Companies Investment Trust (JMI), Schroder Income Growth (SCF), Fidelity Japan Trust (FJV), Pembroke VCT B (PEMB), The Biotech Growth Trust (BIOG), Keystone Investment Trust (KIT), and International Biotechnology (IBT). These companies are all part of the "asset management" industry. Maven Income and Growth VCT 3 vs. Its Competitors CVC Credit Partners European Opportunities Fair Oaks Income 2021 The Independent Investment Trust JPMorgan UK Smaller Companies Investment Trust Schroder Income Growth Fidelity Japan Trust Pembroke VCT B The Biotech Growth Trust Keystone Investment Trust International Biotechnology Maven Income and Growth VCT 3 (LON:MIG3) and CVC Credit Partners European Opportunities (LON:CCPG) are both small-cap asset management industry companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Is MIG3 or CCPG a better dividend stock? Maven Income and Growth VCT 3 pays an annual dividend of GBX 3 per share and has a dividend yield of 6.3%. CVC Credit Partners European Opportunities pays an annual dividend of GBX 0.06 per share. Maven Income and Growth VCT 3 pays out 513.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Is MIG3 or CCPG more profitable? Maven Income and Growth VCT 3 has a net margin of 26.21% compared to CVC Credit Partners European Opportunities' net margin of 0.00%. Maven Income and Growth VCT 3's return on equity of 1.12% beat CVC Credit Partners European Opportunities' return on equity.Company Net Margins Return on Equity Return on Assets Maven Income and Growth VCT 326.21% 1.12% -2.94% CVC Credit Partners European Opportunities N/A N/A N/A Which has higher earnings and valuation, MIG3 or CCPG? Maven Income and Growth VCT 3 has higher revenue and earnings than CVC Credit Partners European Opportunities. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaven Income and Growth VCT 3£2.78M21.25£728.80K£0.5881.07CVC Credit Partners European OpportunitiesN/AN/AN/AN/AN/A Does the media prefer MIG3 or CCPG? In the previous week, Maven Income and Growth VCT 3's average media sentiment score of 1.50 beat CVC Credit Partners European Opportunities' score of 0.00 indicating that Maven Income and Growth VCT 3 is being referred to more favorably in the media. Company Overall Sentiment Maven Income and Growth VCT 3 Very Positive CVC Credit Partners European Opportunities Neutral SummaryMaven Income and Growth VCT 3 beats CVC Credit Partners European Opportunities on 5 of the 7 factors compared between the two stocks. Get Maven Income and Growth VCT 3 News Delivered to You Automatically Sign up to receive the latest news and ratings for MIG3 and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIG3 vs. The Competition Export to ExcelMetricMaven Income and Growth VCT 3Asset Management IndustryFinancial SectorLON ExchangeMarket Cap£59.09M£1.25B£6.17B£3.00BDividend Yield6.56%4.39%4.21%5.02%P/E Ratio81.0722.0713.26150.91Price / Sales21.252,369.191,742.84314,545.51Price / Cash2.7660.81128.0727.97Price / Book0.881.221.914.59Net Income£728.80K£263.98M£1.23B£5.90B7 Day PerformanceN/A14.33%11.16%11.51%1 Month Performance4.41%2.42%6.85%7.90%1 Year Performance-1.25%5.73%17.27%32.03% Maven Income and Growth VCT 3 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIG3Maven Income and Growth VCT 3N/AGBX 47.40+2.2%N/A-1.3%£59.09M£2.78M81.07N/APositive NewsGap UpCCPGCVC Credit Partners European OpportunitiesN/AN/AN/AN/A£224.83MN/A0.00N/AFAIRFair Oaks Income 2021N/AGBX 0.53-2.8%N/A-1.4%£219.71M£3.00B7.55N/AHigh Trading VolumeIITThe Independent Investment TrustN/AN/AN/AN/A£218.27M-£50.48M472.472Gap UpJMIJPMorgan UK Smaller Companies Investment TrustN/AN/AN/AN/A£217.76M-£9.18M-1,743.75N/ASCFSchroder Income GrowthN/AGBX 310-0.3%N/A+7.5%£215.86M£41.03M5.79N/ANews CoverageFJVFidelity Japan TrustN/AGBX 190-1.0%N/A+6.2%£215.86M£8.79M34.29N/APositive NewsPEMBPembroke VCT BN/AGBX 93flatN/A-6.6%£212.13M-£919.80K-32.11N/ABIOGThe Biotech Growth TrustN/AGBX 742+0.5%N/A-23.1%£211.98M£87.94M2.49N/ANews CoveragePositive NewsKITKeystone Investment TrustN/AN/AN/AN/A£211.78M-£52.98M-3.63N/AHigh Trading VolumeIBTInternational BiotechnologyN/AGBX 586-1.3%N/A-8.9%£210.50M£41.82M5.59N/ANews Coverage Related Companies and Tools Related Companies CVC Credit Partners European Opportunities Alternatives Fair Oaks Income 2021 Alternatives The Independent Investment Trust Alternatives JPMorgan UK Smaller Companies Investment Trust Alternatives Schroder Income Growth Alternatives Fidelity Japan Trust Alternatives Pembroke VCT B Alternatives The Biotech Growth Trust Alternatives Keystone Investment Trust Alternatives International Biotechnology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MIG3) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored"I'm risking my reputation on this"Most people think you need thousands to profit from crypto. But this free book exposes how even small inves...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maven Income and Growth VCT 3 PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Maven Income and Growth VCT 3 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIG3 Stock Alerts